Pathogenesis of Alcoholic Fatty Liver a Narrative Review

被引:13
|
作者
Seitz, Helmut K. [1 ]
Moreira, Bernardo [1 ]
Neuman, Manuela G. [2 ]
机构
[1] Heidelberg Univ, Ethianum Clin, Fac Med, Ctr Liver & Alcohol Associated Dis, D-69120 Heidelberg, Germany
[2] Univ Toronto, Temer Fac Med, Dept Pharmacol & Toxicol, In Vitro Drug Safety & Biotechnol,Banting Inst, Toronto, ON M5G OA3, Canada
来源
LIFE-BASEL | 2023年 / 13卷 / 08期
关键词
alcoholic fatty liver; adenosine monophosphate activated kinase; sterol regulatory element binding protein 1c; peroxisome proliferator activated receptor alpha; oxidative stress; OXIDATIVE STRESS; INTESTINAL PERMEABILITY; CYTOCHROME P4502E1; ETHANOL-METABOLISM; GUT MICROBIOTA; KNOCKOUT MICE; DISEASE; INJURY; CYP2E1; WINE;
D O I
10.3390/life13081662
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Alcohol effect hepatic lipid metabolism through various mechanisms, leading synergistically to an accumulation of fatty acids (FA) and triglycerides. Obesity, as well as dietary fat (saturated fatty acids (FA) versus poly-unsaturated fatty acids (PUFA)) may modulate the hepatic fat. Alcohol inhibits adenosine monophosphate activated kinase (AMPK). AMPK activates peroxisome proliferator activated receptor a (PPAR alpha) and leads to a decreased activation of sterol regulatory element binding protein 1c (SRABP1c). The inhibition of AMPK, and thus of PPAR alpha, results in an inhibition of FA oxidation. This ss-oxidation is further reduced due to mitochondrial damage induced through cytochrome P4502E1 (CYP2E1)-driven oxidative stress. Furthermore, the synthesis of FAs is stimulated through an activation of SHREP1. In addition, alcohol consumption leads to a reduced production of adiponectin in adipocytes due to oxidative stress and to an increased mobilization of FAs from adipose tissue and from the gut as chylomicrons. On the other side, the secretion of FAs via very-low-density lipoproteins (VLDL) from the liver is inhibited by alcohol. Alcohol also affects signal pathways such as early growth response 1 (Egr-1) associated with the expression of tumour necrosis factor alpha (TNF alpha), and the mammalian target of rapamycin (mTOR) a key regulator of autophagy. Both have influence the pathogenesis of alcoholic fatty liver. Alcohol-induced gut dysbiosis contributes to the severity of ALD by increasing the metabolism of ethanol in the gut and promoting intestinal dysfunction. Moreover, pathogen-associated molecular patterns (PAMPS) via specific Toll-like receptor (TLR) bacterial overgrowth leads to the translocation of bacteria. Endotoxins and toxic ethanol metabolites enter the enterohepatic circulation, reaching the liver and inducing the activation of the nuclear factor kappa-B (NF kappa B) pathway. Pro-inflammatory cytokines released in the process contribute to inflammation and fibrosis. In addition, cellular apoptosis is inhibited in favour of necrosis.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] A review of synbiotic efficacy in non-alcoholic fatty liver disease as a therapeutic approach
    Sangouni, Abbas Ali
    Ghavamzadeh, Saeid
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (05) : 2917 - 2922
  • [22] Mitochondria-Mediated Pathogenesis and Therapeutics for Non-Alcoholic Fatty Liver Disease
    Li, Zheng
    Li, Yan
    Zhang, Hui-Xia
    Guo, Jian-Ru
    Lam, Christopher Wai Kei
    Wang, Cai-Yun
    Zhang, Wei
    MOLECULAR NUTRITION & FOOD RESEARCH, 2019, 63 (16)
  • [23] Creatine supplementation protects against diet-induced non-alcoholic fatty liver but exacerbates alcoholic fatty liver
    Marinello, Poliana C.
    Cella, Paola S.
    Testa, Mayra T. J.
    Guirro, Phillipe B.
    Brito, Walison Augusto da Silva
    Padilha, Camila S.
    Cecchini, Alessandra L.
    da Silva, Robin P.
    Duarte, Jose Alberto R.
    Deminice, Rafael
    LIFE SCIENCES, 2022, 310
  • [24] The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease
    Scarlata, Giuseppe Guido Maria
    Colaci, Carmen
    Scarcella, Marialaura
    Dallio, Marcello
    Federico, Alessandro
    Boccuto, Luigi
    Abenavoli, Ludovico
    DISEASES, 2024, 12 (04)
  • [25] n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review
    Wang, Meng
    Ma, Li-Juan
    Yang, Yan
    Xiao, Zeyu
    Wan, Jian-Bo
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2019, 59 (Sup 1) : S116 - S129
  • [26] Literature Review on the Use of Herbal Extracts in the Treatment of Non-Alcoholic Fatty Liver Disease
    Wang, Yutian
    Wu, Junzi
    Shi, Anhua
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022, 22 (11) : 1123 - 1145
  • [27] Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review
    Sabirin, Faezah
    Lim, Siong Meng
    Neoh, Chin Fen
    Ramasamy, Kalavathy
    FRONTIERS IN NUTRITION, 2022, 9
  • [28] Effects of probiotics on non-alcoholic fatty liver disease: a review of human clinical trials
    Cao, Chujin
    Shi, Mengxia
    Wang, Xiuru
    Yao, Ying
    Zeng, Rui
    FRONTIERS IN NUTRITION, 2023, 10
  • [29] Pathogenesis of Alcoholic Liver Disease: An Update
    Kourkoumpetis, Themistoklis
    Sood, Gagan
    CLINICS IN LIVER DISEASE, 2019, 23 (01) : 71 - +
  • [30] Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
    Bovi, Anna Pia Delli
    Marciano, Francesca
    Mandato, Claudia
    Siano, Maria Anna
    Savoia, Marcella
    Vajro, Pietro
    FRONTIERS IN MEDICINE, 2021, 8